BIOA
BioAge Labs, Inc
NASDAQ: BIOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.85
-0.06% today
Updated 2026-04-30
Market cap
$756.98M
P/E ratio
—
P/S ratio
84.16x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$4 – $24
Volume
0.5M
BioAge Labs, Inc (BIOA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-923.00%
ROE
-27.10%
ROA
-17.80%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $2.67M | $-33.22M | -0.89% | -1,545.08% | -1,246.33% |
| 2014 | $1.54M | $-46.42M | -291.68% | -2,281.51% | -3,008.45% |
| 2015 | $2.17M | $-37.23M | -20.30% | -1,773.92% | -1,713.94% |
| 2016 | $8.27M | $-22.48M | -65.21% | -358.17% | -271.72% |
| 2017 | $14.94M | $-98.15M | -49.39% | -736.22% | -656.84% |
| 2022 | $0.00 | $-39.72M | — | — | — |
| 2023 | $0.00 | $-63.85M | — | — | — |
| 2024 | $0.00 | $-71.11M | — | — | — |
| 2025 | $8.99M | $-80.61M | 100.00% | -1,031.46% | -896.11% |